RxAdvocate May, 2024 — Newsletter
FDA Approves New Drug for the Treatment of NASH
FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva
April Recognizes National Infertility Awareness Week
Easter Weekend and Family Time
Stay up-to-date with the latest trends in the healthcare industry via our News, Events and quarterly Newsletters.
FDA Approves New Drug for the Treatment of NASH
FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva
April Recognizes National Infertility Awareness Week
Easter Weekend and Family Time
FDA Approves New Drug for the Treatment of NASH
FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva
April Recognizes National Infertility Awareness Week
Easter Weekend and Family Time
Wegovy Approved to Decrease Cardiovascular Risk
Oprah’s Recent Take on Weight Loss Medications & What You Should Know
FDA Approves New Gene Therapy
Employee Spotlight
Weight Loss Products: Should Employers Cover?
FDA Approves New Weight Loss Drug, Zepbound
Enter your email address to receive our newsletter.